Cohort A: ORMD-0801
ORA-D-015
Phase 2 small_molecule completed
Quick answer
Cohort A: ORMD-0801 for T2DM (Type 2 Diabetes Mellitus) is a Phase 2 program (small_molecule) at ORAMED PHARMACEUTICALS INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ORAMED PHARMACEUTICALS INC.
- Indication
- T2DM (Type 2 Diabetes Mellitus)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed